Le Lézard
Classified in: Science and technology
Subject: Personnel

Further Organizational Change Brings Further FHIR® Expertise to VirtualHealth


VirtualHealth is pleased to announce another organizational change that will bring about heightened innovation and expertise for our customers seeking to solve for new prior authorization APIs and FHIR® interoperability this year.

On that note, we are pleased to announce the addition of Drew Hannah as our new Vice President of Sales.

Hannah has led omnichannel distribution sales strategies for more than 25 years and was most recently the Director of Business Development at Smile Digital Health (Smile CDR). Drew was also a founding member of the FHIR Business Alliance, helping to drive industry alignment to the FHIR standard. His experience and industry leadership in the clinical data repository space and with FHIR will benefit existing HELIOS clients and new organizations looking to achieve healthcare interoperability and execute a more effective and connected data management approach.

"The entire VirtualHealth team is thrilled to have a veteran industry expert like Drew with a wealth of FHIR expertise joining the VirtualHealth team," said Rick Auletta, President & Chief Operating Officer at VirtualHealth. "I think it says a lot about the quality of the HELIOS product and VirtualHealth's momentum in the industry that so many seasoned professionals have recently chosen to take the next step in their careers with us. We look forward to this year and seeing how our evolving team will continue to make our products and customer experience the best in the industry."

Hannah joins the VirtualHealth team following the addition of Sameer Gaikwad as VirtualHealth's new Vice President of Account Management and Customer Success and the promotion of Marcus Caraballo to Chief Product Officer.

To learn more about the VirtualHealth leadership team, click here.

Want to explore job opportunities at VirtualHealth yourself? View open careers here.

About HELIOS & VirtualHealth

VirtualHealth is dedicated to empowering healthcare organizations to provide the exceptional value-based care that members need to change their lives for the better. To do this, VirtualHealth created the industry-leading medical management platform HELIOS® to meet the needs of government health plans, commercial payers, health systems, and specialty providers. Trusted by some of the largest and most innovative healthcare organizations, HELIOS supports care and disease management, population health, utilization management, FHIR data interoperability, and more. Unrivaled in the industry with 90% configurability, HELIOS utilizes AI, powerful automations, and unlimited clinical workflows and integrations to enable faster and more effective care. Intuitive and easy to use, VirtualHealth's solutions help remove provider-payer frictions, lower operational and administrative costs, and drive productivity and efficiency gains, all while maintaining compliance. To learn more, visit www.virtualhealth.com.

The original version of this press release can be viewed here.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: